“Long-Term Safety and Efficacy of Tralokinumab in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years”. 2025. SKIN The Journal of Cutaneous Medicine 9 (2): s573. https://doi.org/10.25251/skin.10.supp.573.